dc.contributor.author | Overgaard, J | |
dc.contributor.author | Abeyakoon, S | |
dc.contributor.author | Hadjieva, T | |
dc.contributor.author | Turkan, S | |
dc.contributor.author | Tatsuzaki, H | |
dc.contributor.author | Dinshaw, KA | |
dc.contributor.author | Wahid, I | |
dc.contributor.author | Grau, C | |
dc.contributor.author | Agarwal, JP | |
dc.contributor.author | Jabeen, K | |
dc.contributor.author | Khan, AR | |
dc.date.accessioned | 2021-03-05T19:49:11Z | |
dc.date.available | 2021-03-05T19:49:11Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Grau C., Agarwal J., Jabeen K., Khan A., Abeyakoon S., Hadjieva T., Wahid I., Turkan S., Tatsuzaki H., Dinshaw K., et al., "Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial", RADIOTHERAPY AND ONCOLOGY, cilt.67, ss.17-26, 2003 | |
dc.identifier.issn | 0167-8140 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_d1062a27-ff09-47dd-8e8c-27d188effbdc | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/138178 | |
dc.identifier.uri | https://doi.org/10.1016/s0167-8140(03)00020-3 | |
dc.description.abstract | Background and purpose: Single agent mitomycin c (MMC) has been shown to improve the outcome of radiotherapy in single institution trials. In order to confirm these findings in a broader worldwide setting, the International Atomic Energy Agency (IAEA) initiated a multicentre trial randomising between radiotherapy alone versus radiotherapy plus MMC. | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Nükleer Tıp | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial | |
dc.type | Makale | |
dc.relation.journal | RADIOTHERAPY AND ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 67 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 17 | |
dc.identifier.endpage | 26 | |
dc.contributor.firstauthorID | 168208 | |